1. Weber, Sarah, Koschade, Sebastian E, Hoffmann, Christopher M, Glimm, Hanno, Ball, Claudia R. 2019. The notch target gene HEYL modulates metastasis forming capacity of colorectal cancer patient-derived spheroid cells in vivo. In BMC cancer, 19, 1181. doi:10.1186/s12885-019-6396-4. https://pubmed.ncbi.nlm.nih.gov/31796022/
2. Han, Liangfeng, Korangath, Preethi, Nguyen, Nguyen K, Romer, Lewis, Sukumar, Saraswati. 2021. HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium. In Frontiers in oncology, 10, 581459. doi:10.3389/fonc.2020.581459. https://pubmed.ncbi.nlm.nih.gov/33520697/
3. Kuo, Kung-Kai, Jian, Shu-Fang, Li, Yi-Jin, Wu, Deng-Chyang, Cheng, Kuang-Hung. 2014. Epigenetic inactivation of transforming growth factor-β1 target gene HEYL, a novel tumor suppressor, is involved in the P53-induced apoptotic pathway in hepatocellular carcinoma. In Hepatology research : the official journal of the Japan Society of Hepatology, 45, 782-93. doi:10.1111/hepr.12414. https://pubmed.ncbi.nlm.nih.gov/25179429/